Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 27, 1997

View Archived Issues

Dusa announces initiation of bladder cancer photodetection study and Q3 1997 highlights

Cytogen: Q3 1997 highlights

Immunomedics: Q1 1998 highlights

Alpharma: Q3 1997 highlights

New erythromycins discovered at Roussel Uclaf

Genetronics cleared to start electroporation therapy phase II trial in U.S.

Clinical efficacy of naltrexone demonstrated in patients with cholestatic pruritus

Cephalon and TAP renew oncology collaboration

Stress proteins shown to activate CTL response to cancer cells

Ono accelerates overseas development of neurologic drug

Beaufour-Ipsen moves TH-9506 to phase I

Ono's elastase inhibitor poised to enter phase I in Europe

AnorMED's AMD-473 enters phase I

New V1 antagonists disclosed by Yamanouchi

WB-2663B, a novel immunosuppressant isolated from Pseudomonas

Agents activating beta3-adrenoceptors from Pfizer

Cathepsin L inhibitors with broad therapeutic potential from Takeda

Pharmacological profile of TH-142177, a new AT1 receptor antagonist

Abbott improves on the pharmacological profiles of its ChCM candidates

SB-205384 associated with temporal modulation of GABA-gated currents

Profile of hepatoprotective activity of picroliv in rats

Controlled trial of ofloxacin + IFN-alpha-2b in chronic hepatitis C

Tolcapone reduces "wearing-off" phenomonen in Parkinson's disease patients

RPR merger with Rhone-Poulenc finalized

Launch of Ligand/Lilly metabolic disease alliance

FACT study results reported

FDA clears Zomig

First anticancer monoclonal antibody approved by FDA

Bronchodilating mechanism of PDE IV inhibitors investigated using CP-80633

SmithKline Beecham and Cephalon terminate calpain inhibitor collaboration

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...